tiprankstipranks
enGene Holdings (ENGN)
NASDAQ:ENGN
US Market

Compare enGene Holdings (ENGN) vs. Competitors

305 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
enGene Holdings
$7.33
$489.69M
-5.39
77.43%
6 Buy
1 Hold
0 Sell
Strong Buy
Tvardi Therapeutics
$3.05
$28.61M
-1.75
-79.04%
4 Buy
3 Hold
0 Sell
Moderate Buy
Capricor Therapeutics
$31.60
$1.82B
-12.77
263.22%
8 Buy
0 Hold
0 Sell
Strong Buy
Replimune Group
$5.88
$485.94M
-3.16
-17.58%
1 Buy
2 Hold
0 Sell
Moderate Buy
Immuneering
$5.50
$355.59M
-6.25
340.00%
5 Buy
0 Hold
0 Sell
Strong Buy
Contineum Therapeutics, Inc. Class A
$12.79
$495.70M
-5.28
167.01%
5 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ENGN
enGene Holdings
7.31
3.28
81.39%
TVRD
Tvardi Therapeutics
3.05
-11.65
-79.25%
CAPR
Capricor Therapeutics
31.60
22.20
236.17%
REPL
Replimune Group
5.89
-1.42
-19.49%
IMRX
Immuneering
5.50
4.21
326.36%
CTNM
Contineum Therapeutics, Inc. Class A
12.79
8.17
176.84%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts